ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) | ||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
• | “amended and restated memorandum and article of association” are to our amended and restated memorandum and articles of association adopted in connection with our Initial Public Offering; |
• | “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time; |
• | “founder shares” are to our Class B ordinary shares initially issued to our sponsor in a private placement prior to our Initial Public Offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof (for the avoidance of doubt, such Class A ordinary shares will not be “public shares”); |
• | “Initial Public Offering” are to the company’s offering on December 16, 2020 of 40,000,000 units (which includes an additional 5,000,000 units sold pursuant to the partial exercise of the underwriter’s over-allotment option) at a price of $10.00 per unit, each unit consisting of one Class A ordinary share and one-third of one redeemable warrant; |
• | “initial shareholders” are to our sponsor and each other holder of founder shares upon the consummation of our Initial Public Offering; |
• | “management” or our “management team” are to our executive officers and directors; |
• | “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares; |
• | “private placement warrants” are to the warrants that were issued to our sponsor in a private placement simultaneously with the closing of our Initial Public Offering and to be issued upon conversion of working capital loans, if any; |
• | “public shares” are to our Class A ordinary shares sold as part of the units in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market); |
• | “public shareholders” are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided |
• | “sponsor” are to CGA Sponsor, LLC, a Delaware limited liability company; |
• | “U.S. Holder” means a beneficial owner of units, Class A ordinary shares or warrants that is for U.S. federal income tax purposes (i) an individual citizen or resident of the United States, (ii) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) that is created or organized (or treated as created or organized) in or under the laws of the United States, any state thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) a trust if (A) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (B) it has in effect under applicable U.S. Treasury regulations a valid election to be treated as a U.S. person; and |
• | “we,” “us,” “our,” “company,” “our company” or “Corner Growth” are to Corner Growth Acquisition Corp., a Cayman Islands exempted company. |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of a prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses (including Corner Growth Acquisition Corp. 2 and Corner Growth Acquisition Corp. 3) and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance following our Initial Public Offering. |
• | Management distraction : Preparation for and execution of an IPO requires management teams to devote considerable time and attention to the lengthy IPO process, including document drafting, underwriter selection and extensive investor engagement. This significant commitment can potentially distract management teams from focusing on the company’s product and growth strategies, a particularly challenging dynamic for high-growth technology company executives. |
• | Price discovery and shareholder base development : The process for technology IPO demand generation often produces IPO order books that are significantly oversubscribed, but lacks an effective price discovery mechanism and encourages participation from many investors that are focused on short-term performance. Furthermore, limited price discovery and short-term focused investors can create a misalignment of incentives during the IPO share allocation process between technology companies and their underwriters. The current technology IPO book-build process fails to deliver the requisite information to technology company management teams, pre-IPO stakeholders and underwriters to make informed judgements regarding IPO pricing and allocation decisions and alternatives. |
• | Longer-term impacts : A technology IPO book build that is characterized by ineffective price discovery and initial public shareholder base development can lead to material longer-term negative impacts for companies completing an IPO, such as shareholder base turnover and increased share price volatility. These dynamics have far reaching effects on newly public companies and can impair a management team’s ability to focus on long-term value creation. |
• | are in the technology industry and can benefit from the extensive networks and insights we have built. In addition, we expect to evaluate targets in related industries that can use technology to drive meaningful operational improvements and efficiency gains, or enhance their strategic positions by using technology solutions to differentiate offerings; |
• | are ready to operate in the scrutiny of public markets, with strong management, corporate governance and reporting policies in place; |
• | will likely be well received by public investors and are expected to have good access to the public capital markets; |
• | are at an inflection point, such as those requiring significant additional capital to fund growth and expand operations, drive innovation, require additional operational expertise, or seek international exposure; |
• | have significant embedded and/or underexploited expansion opportunities; |
• | exhibit unrecognized value or other characteristics that we believe have been misevaluated by the market based on our company-specific analysis and due diligence review. For a potential target company, this process will include, among other things, a review and analysis of the company’s capital structure, quality of earnings, if any, potential for growth and operational improvements, corporate governance, customers, material contracts, and industry background and trends; and |
• | will offer attractive risk-adjusted equity returns for our shareholders. Financial returns will be evaluated based on the (1) potential for organic growth in revenue and cash flows, (2) ability to accelerate growth, including through the opportunity for follow-on acquisitions and (3) prospects for creating value through other value creation initiatives. Potential upside from growth in the target business’ earnings and an improved capital structure will be weighed against any identified downside risks. |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | we issue (other than in a public offering for cash) ordinary shares that will either (a) be equal to or in excess of 20% of the number of Class A ordinary shares then outstanding or (b) have voting power equal to or in excess of 20% of the voting power then outstanding; |
• | any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares or voting power of 5% or more; or |
• | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a shareholder vote; |
• | the risk that the shareholders would fail to approve the proposed business combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | We are a recently incorporated company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Past performance by our management team or their respective affiliates, including may not be indicative of future performance of an investment in us. |
• | Our expectations regarding changes and growth in the technology industry may not materialize to the extent we expect, or at all. |
• | Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a combination. |
• | Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
• | If we seek shareholder approval of our initial business combination, our sponsor and members of our management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
• | The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares. |
• | The requirement that we consummate an initial business combination within 24 months after the closing of our Initial Public Offering may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that could produce value for our shareholders. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) outbreak and the status of debt and equity markets. |
• | We may not be able to consummate an initial business combination within 24 months after the closing of our Initial Public Offering, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.00 per share, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | If we seek shareholder approval of our initial business combination, our sponsor, directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or public warrants. |
• | If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not consummated our initial business combination within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. |
• | Since our sponsor, executive officers, directors and other affiliates will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after our Initial Public Offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. |
• | We are dependent upon our executive officers and directors and their loss could adversely affect our ability to operate. |
• | Our executive officers and directors will allocate their time to other businesses, including Corner Growth 2 and Corner Growth 3, thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination. |
• | Our officers and directors presently have, and any of them in the future may have, additional fiduciary or contractual obligations to other entities, including Corner Growth 2 and Corner Growth 3, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares. |
• | Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited. |
• | Provisions in our amended and restated memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench management. |
• | Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; and |
• | deterioration of political relations with the United States. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our Class A ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock,” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | may significantly dilute the equity interest of investors in our Initial Public Offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, |
• | registration as an investment company with the SEC; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of the Nasdaq; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | we have a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
Page |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
Name |
Age |
Position | ||||
John Cadeddu |
54 | Co-Chairman and Director | ||||
Marvin Tien |
46 | Co-Chairman, Chief Executive Officer and Director | ||||
Alexandre Balkanski |
60 | Director Nominee | ||||
John Mulkey |
47 | Director Nominee | ||||
Jason Park |
44 | Director Nominee | ||||
Jane Batzofin |
46 | President | ||||
Jerome “Jerry” Letter |
46 | Chief Financial Officer and Chief Operating Officer | ||||
David Kutcher |
38 | Chief Investment Officer | ||||
Kevin Tanaka |
30 | Director of Corporate Development |
• | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
• | monitoring the independence of the independent registered public accounting firm; |
• | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
• | inquiring and discussing with management our compliance with applicable laws and regulations; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports that raise material issues regarding our financial statements or accounting policies; |
• | monitoring compliance on a quarterly basis with the terms of our Initial Public Offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of our Initial Public Offering; and |
• | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. |
• | should have demonstrated notable or significant achievements in business, education or public service; |
• | should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
• | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, if any is paid by us, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
• | reviewing and approving the compensation of all of our other Section 16 executive officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | directors should not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
John Cadeddu | Corner Ventures | Venture Firm | Co-founder, General Partner | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Co-Chairman, Director | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Co-Chairman, Director | ||||
CommonSense Robotics Ltd. (d/b/a Fabric) | Logistics automation | Director | ||||
Prismo Systems Inc. | Cybersecurity | Director | ||||
Picarro, Inc. | Electronic equipment and instruments | Director | ||||
Marvin Tien | Corner Ventures (1) |
Venture Firm | Co-founder, General Partner | |||
Corner Capital Group (1) |
Investment Firm | General Partner | ||||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Co-Chairman, Chief Executive Officer,Director | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Co-Chairman, Chief Executive Officer,Director | ||||
Healthy.io Ltd. | Healthcare technology | Director | ||||
Nexar Inc. | Artificial Intelligence | Director | ||||
Legal Logic Ltd. (d/b/a LawGeex) | Legal contract automation | Director | ||||
Alexandre Balkanski | Picarro, Inc. | Electronic equipment and instruments | President, Chief Executive Officer and Director | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Director Nominee | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Director Nominee | ||||
D2s, Inc. | Software and tech services | Director | ||||
Engageli, Inc. | Digital learning | Director | ||||
John Mulkey | Mulkey Holdings | Hospitality, real estate, gaming and lodging | Manager | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Director Nominee | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Director Nominee | ||||
Jason Park | DraftKings Inc. | Consumer discretionary services | Chief Financial Officer | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Director Nominee | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Director Nominee | ||||
Jane Batzofin | Corner Ventures (1) |
Venture Firm | Partner, General Counsel |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Corner Capital Group (1) |
Investment Firm | Partner, General Counsel | ||||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | President | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | President | ||||
TILT Holdings Inc. | Cannabis holding company | Director | ||||
Jerry Letter | Corner Ventures (1) |
Venture Firm | Partner, Chief Financial Officer and Chief Operating Officer | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Chief Financial Officer and Chief Operating Officer | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Chief Financial Officer and Chief Operating Officer | ||||
Selina Holding Company SE | Hotel Group | Director | ||||
David Kutcher | Corner Ventures (1) |
Venture Firm | Venture Partner | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Chief Investment Officer | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Chief Investment Officer | ||||
Kevin Tanaka | Corner Ventures (1) |
Venture Firm | Principal | |||
Corner Growth Acquisition Corp. 2 | Technology focused SPAC | Director of Corporate Development | ||||
Corner Growth Acquisition Corp. 3 | Technology focused SPAC | Director of Corporate Development |
(1) | Includes certain of its funds and other affiliates. |
• | Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our sponsor subscribed for founder shares and purchased private placement warrants in a transaction that closed simultaneously with the closing of our Initial Public Offering. |
• | Our sponsor and each member of our management team have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our Initial Public Offering or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. Additionally, our sponsor has agreed to waive its rights to liquidating distributions from the trust account with respect to its founder shares if we fail to complete our initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein, pursuant to a letter agreement that our sponsor and each member of our management team have entered into with us, our sponsor and each member of our management team have agreed not to transfer, assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business combination. Because each of our executive officers and directors own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any agreement with respect to our initial business combination. In addition, our sponsor, officers and directors may sponsor, form or participate in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment mandates. |
• | each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; |
• | each of our executive officers and directors that beneficially owns our ordinary share; and |
• | all our executive officers and directors as a group. |
Class B Ordinary Shares |
Class A Ordinary Shares |
Approximate Percentage of Voting Control |
||||||||||||||||||
Name of Beneficial Owner(1) |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
||||||||||||||||
CGA Sponsor, LLC (our sponsor) (2)(3) |
9,825,001 | 98.3 | % | — | — | 19.7 | % | |||||||||||||
Aristeia Capital, L.L.C. (4) |
— | — | 2,300,000 | 5.75 | % | 4.6 | % | |||||||||||||
John Cadeddu (2)(3) |
9,825,001 | 98.3 | % | — | — | 19.7 | % | |||||||||||||
Marvin Tien (2)(3) |
9,825,001 | 98.3 | % | — | — | 19.7 | % | |||||||||||||
Jane Batzofin |
— | — | — | — | — | |||||||||||||||
Jerry Letter |
— | — | — | — | — | |||||||||||||||
David Kutcher |
— | — | — | — | — | |||||||||||||||
Kevin Tanaka |
— | — | — | — | — | |||||||||||||||
Alexandre Balkanski |
58,333 | * | — | — | * | |||||||||||||||
John Mulkey |
58,333 | * | — | — | * | |||||||||||||||
Jason Park |
58,333 | * | — | — | * | |||||||||||||||
All officers and directors as a group (9 individuals) |
10,000,000 | 100.0 | % | — | — | 20.0 | % |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of our shareholders is 251 Lytton Avenue, Suite 200, Palo Alto, California 94301. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof pursuant to the terms of our amended and restated memorandum and articles of incorporation. |
(3) | The shares reported above are held in the name of our sponsor. Our sponsor is controlled by John Cadeddu and Marvin Tien. |
(4) | Consists of 2,300,000 Units and includes Class A ordinary shares underlying Units, each Unit comprising 1 share of Class A ordinary share and one-third of one redeemable warrant, based solely on the Schedule 13G filed by Aristeia Capital, L.L.C. with the SEC on February 16, 2021. Aristeia Capital, L.L.C. is the investment manager of, and has voting and investment control with respect to the securities described herein held by, one or more private investment funds. Aristeia Capital, L.L.C.’s business address is One Greenwich Plaza, 3rd Floor, Greenwich, CT 06830. |
* | Filed herewith |
** | Furnished herewith |
CORNER GROWTH ACQUISITION CORP. | ||
/s/ Marvin Tien | ||
Name: |
Marvin Tien | |
Title: | Co-Chairman and Chief Executive Officer(Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Marvin Tien Marvin Tien |
Co-Chairman, Chief Executive Officer and Director(Principal Executive Officer) |
January 5, 2022 | ||
/s/ Jerome Letter Jerome Letter |
Chief Financial Officer and Chief Operating Officer (Principal Financial and Accounting Officer) |
January 5, 2022 | ||
/s/ John Cadeddu John Cadeddu |
Co-Chairman and Director |
January 5, 2022 | ||
/s/ Alexandre Balkanski Alexandre Balkanski |
Director | January 5, 2022 | ||
/s/ John Mulkey John Mulkey |
Director | January 5, 2022 | ||
/s/ Jason Park Jason Park |
Director | January 5, 2022 |
Page |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
/s/ Marcum LLP |
Marcum LLP |
ASSETS |
||||
Current assets |
||||
Cash |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total Current Assets |
||||
Marketable securities held in trust account |
||||
|
|
|||
Total Assets |
$ | |||
|
|
|||
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
||||
Current Liabilities |
||||
Offering Costs Payable |
$ | |||
Accrued Expenses |
||||
Accounts Payable |
||||
|
|
|||
Total Current Liabilities |
||||
Warrant liabilities Deferred underwriting fee payable |
| |||
|
|
|||
Total Liabilities |
||||
|
|
|||
COMMITMENTS |
||||
Class A ordinary shares subject to possible redemption, |
||||
Shareholders’ Deficit |
||||
Preference Shares, $ par value, |
||||
Class A ordinary Shares, $ par value, |
||||
Class B ordinary Shares, $ par value, |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total Shareholders’ Deficit |
$ | ( |
) | |
|
|
|||
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
$ | |
||
|
|
Operating and formation costs |
$ | |||
|
|
|||
Loss from operations |
( |
) | ||
Other Income (Loss): |
||||
Unrealized gain on marketable securities held in Trust Account |
||||
Transaction costs |
( |
) | ||
Change in fair value of warrant liabilities |
( |
) | ||
|
|
|||
Net loss |
$ | ( |
) | |
|
|
|||
Basic and diluted weighted average shares outstanding of Class A ordinary shares |
||||
|
|
|||
Basic and diluted net loss per ordinary share, Class A |
$ | ( |
) | |
|
|
|||
Basic and diluted weighted average shares outstanding of Class B ordinary shares |
||||
|
|
|||
Basic and diluted net loss per ordinary share, Class B |
$ | ( |
) | |
|
|
Class A |
Class B |
Total |
||||||||||||||||||||||||||
Ordinary Shares |
Ordinary Shares |
Additional Paid- in Capital |
Accumulated Deficit |
Shareholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - October 20, 2020 (inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Issuance of Class B ordinary shares to initial shareholders |
— | — | — | |||||||||||||||||||||||||
Forfeiture of Class B ordinary shares by initial shareholders |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Accretion of Class A ordinary shares subject to possible redemption |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Excess cash received over fair value of Private Placement Warrants |
— | — | — | — | — | |||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
BALANCE, DECEMBER 31, 2020 |
$ | $ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Unrealized gain on marketable securities held in Trust Account |
( |
) | ||
Change in fair value of warrant liabilities Transaction costs allocable to warrant liabilities |
| |||
Changes in operating assets and liabilities: |
||||
Accounts payable |
||||
Accrued expenses |
||||
Prepaid expenses |
( |
) | ||
Net cash used in operating activities |
( |
) | ||
Cash Flows used in Investing Activities |
||||
Investment of cash in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities |
||||
Proceeds from promissory note—related party |
||||
Repayment of promissory note—related party |
( |
) | ||
Proceeds from issuance of Class B ordinary shares to Sponsor |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Warrants |
||||
Payment of offering costs |
( |
) | ||
Net cash provided by financing activities |
||||
Net change in cash |
||||
Cash at beginning of the period |
||||
Cash at end of the period |
$ | |||
Non-cash investing and financing activities: |
||||
Initial classification of ordinary shares subject to possible redemption |
$ |
|||
Deferred underwriting fee |
$ |
|||
Initial classification of warrant liabilities |
$ |
|||
Offering costs payable |
$ | |||
As Previously Reported in Form 10-K |
Adjustments |
As Restated in Form 10-K/A, Amendment No. 1 |
||||||||||
Balance Sheet as of December 31, 2020 |
||||||||||||
Warrant liabilities |
$ |
— |
$ |
$ |
||||||||
Total liabilities |
||||||||||||
Class A ordinary shares subject to possible redemption |
( |
) |
||||||||||
Class A ordinary shares |
||||||||||||
Additional paid-in capital |
||||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Shareholders’ Equity |
$ |
$ |
— |
$ |
||||||||
Number of Class A ordinary shares subject to redemption |
( |
) |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the Period From October 20, 2020 (inception) through December 31, 2020 |
||||||||||||
Change in fair value of warrant liabilities |
$ |
— |
$ |
( |
) |
$ |
( |
) | ||||
Transaction costs |
— |
( |
) |
( |
) | |||||||
Other income (loss), net |
( |
) |
( |
) | ||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Basic and diluted weighted average shares outstanding, Redeemable ordinary shares |
( |
) |
||||||||||
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares |
||||||||||||
Basic and diluted net loss per share, Non-redeemable ordinary shares |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Statement of Changes in Shareholders’ Equity for the Period From October 20, 2020 (inception) through December 31, 2020 |
||||||||||||
Class A ordinary shares |
$ | $ | $ | |||||||||
Additional paid-in capital |
||||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
Total Shareholders’ Equity |
$ | $ |
$ | |||||||||
Class A ordinary shares subject to possible redemption |
( |
) | ||||||||||
Statement of Cash Flows for the Period From October 20, 2020 (inception) through December 31, 2020 |
||||||||||||
Cash Flows from Operating Activities: |
||||||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Change in fair value of warrant liabilities |
— |
|||||||||||
Transaction costs allocable to warrant liabilities |
— |
As Previously Reported in Form 10-K/A, Amendment No. 1 |
Adjustments |
As Restated |
||||||||||
Balance sheet as of December 31, 2020 |
||||||||||||
Class A ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
Class A ordinary shares, $ |
( |
) |
||||||||||
Class B ordinary shares, $ |
||||||||||||
Additional paid-in capital |
( |
) |
||||||||||
Accumulated deficit |
( |
) |
( |
) |
( |
) | ||||||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) |
$ | ( |
) | |||||
Number of Class A ordinary shares subject to redemption |
||||||||||||
EPS for Class A ordinary shares (redeemable) |
||||||||||||
Statement of operations for the period from October 20, 2020 (inception) through December 31, 2020 |
As Previously Reported in Form 10-K/A, Amendment No. 1 |
Adjustments |
As Restated |
|||||||||
Allocation of net income (loss) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted loss per share |
$ |
$ |
( |
) |
$ |
( |
) | |||||
EPS for Class B ordinary shares (non-redeemable) |
||||||||||||
Statement of operations for the period from October 20, 2020 (inception) through December 31, 2020 |
As in Form 10-K/A, Amendment No. 1 |
Adjustment s |
As Restated |
|||||||||
Allocation of net loss |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Weighted average shares outstanding |
( |
) |
||||||||||
Basic and diluted loss per share |
$ |
( |
) |
$ |
$ |
( |
) | |||||
As Previously Reported in Form 10-K/A Amendment No. 1 |
Adjustments |
As Restated |
||||||||||
Statement of Changes in Shareholders’ Equity (Deficit) for the Period From October 20, 2020 (inception) through December 31, 2020 |
||||||||||||
Class A ordinary shares |
$ | $ | ( |
) | $ | |||||||
Additional paid-in capital |
( |
) | ||||||||||
Accumulated deficit |
( |
) | ( |
) | ( |
) | ||||||
Total Shareholders’ Equity (Deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Class A ordinary shares subject to possible redemption |
( |
) |
Statement of Cash Flows for the period from October 20, 2020 (inception) through December 31, 2020 |
As Previously Reported in Form 10-K/A, Amendment No. 1 |
Adjustments |
As Restated |
|||||||||
Initial classification of Class A ordinary shares subject to redemption |
$ |
$ |
$ |
|||||||||
Change in value of Class A ordinary shares subject to possible redemption |
( |
) |
|
Gross proceeds |
$ |
|||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A ordinary share issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A ordinary shares subject to possible redemption |
$ |
Class A |
Class B |
|||||||
Basic and diluted net loss per ordinary share: |
||||||||
Numerator: |
||||||||
Allocation of net loss |
$ | ( |
) | $ | ( |
) | ||
Denominator: |
||||||||
Basic and diluted weighted average ordinary shares outstanding |
||||||||
Basic and diluted net loss per ordinary share |
$ | ( |
) | $ | ( |
) | ||
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description |
Level |
December 31, 2020 |
||||||
Assets: |
||||||||
Marketable securities held in trust account |
1 | $ |
Description |
Level |
December 31, 2020 |
||||||
Liabilities: |
||||||||
Warrant liabilities – Public Warrants |
1 | $ | ||||||
Warrant liabilities – Private Placement Warrants |
3 | $ | ||||||
|
|
|||||||
Total Warrant liabilities |
$ | |||||||
|
|
Input |
December 21, 2020 (Initial Measurement ) |
December 31, 2020 (Subsequent Measurement ) |
||||||
Risk-free interest rate |
% | % | ||||||
Expected term (years) |
||||||||
Expected volatility |
% | % | ||||||
Exercise price |
$ | $ | ||||||
Fair value of the ordinary share price |
$ | $ | ||||||
Redemption threshold price |
$ | $ | ||||||
Redemption threshold days |
||||||||
Redemption price |
$ | $ |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of December 21, 2020 |
$ | $ | $ | |||||||||
Initial measurement on December 21, 2020 |
||||||||||||
Change in valuation inputs or other assumptions |
||||||||||||
Fair value as of December 31, 2020 |
$ | |
$ | |
$ | |